Analysis of preservatives and fragrances in topical medical devices: The need for more stringent regulation
Contact Dermatitis · 2024
DOI: 10.1111/cod.14533 ↗Kurz gefasst
Fachartikel in der Zeitschrift Contact Dermatitis, 2024. Verfasst von Ania Stras und 5 weiteren Autor:innen. Beteiligte Einrichtung: Medicines and Health Products, Sciensano, Elsene, Belgium. Hauptthemen laut MEDLINE: Preservatives, Pharmaceutical, Gas Chromatography-Mass Spectrometry. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 58 Literaturangaben.
Abstract (Originalsprache)
Introduction
Medical devices (MDs) have a long history of use, and come with regulatory frameworks to ensure user safety. Although topically applied MDs in the form of gels and creams might be used on damaged skin, their composition is often similar to that of cosmetic products applicable to intact skin, especially in terms of preservatives and fragrances. However, unlike cosmetics, these products are not subject to compound‐specific restrictions when used in MDs.
Objective
This study aimed to identify and quantify preservatives and fragrances in topically applied MDs and assess their safety towards the Cosmetic Regulation (EC) 1223/2009.
Method
Sixty‐nine MDs available on the EU market were subjected to previously validated liquid chromatography tandem mass spectrometry (LC–MS/MS) and gas chromatography–mass spectrometry (GC–MS) methods to identify and quantify occurring preservatives and fragrances.
Results
Findings revealed that 32% of the examined MDs did not provide comprehensive ingredient lists, leaving users uninformed about potential risks associated with product use. Furthermore, 30% of these MDs would not meet safety standards for cosmetic products and, most significantly, 13% of the analysed samples contained ingredients that are prohibited in leave‐on cosmetics.
Conclusion
Results highlight the pressing demand for more stringent requirements regarding the labelling and composition of MDs to enhance patient safety. Improved regulation and transparency can mitigate potential risks associated with the use of topically applied MDs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Medicines and Health Products, Sciensano, Elsene, Belgium.
- Department In Vitro Toxicology and Dermato-Cosmetology (IVTD), Vrije Universiteit Brussel, Jette, Belgium.
- Université Catholique de Louvain, Wolluwe-Saint-Lambert, Belgium.
ORCID-Profile: Ania Stras, Bart Desmedt
Zitieren
APA
Stras, A., Grassmann, A., Van Campenhout, P., Deconinck, E., Vanhaecke, T., & Desmedt, B. (2024). Analysis of preservatives and fragrances in topical medical devices: The need for more stringent regulation. Contact Dermatitis. https://doi.org/10.1111/cod.14533
Vancouver
Stras A, Grassmann A, Van Campenhout P, Deconinck E, Vanhaecke T, Desmedt B. Analysis of preservatives and fragrances in topical medical devices: The need for more stringent regulation. Contact Dermatitis. 2024. doi:10.1111/cod.14533
BibTeX
@article{Stras2024,
author = {Stras, Ania and Grassmann, Aleksandra and Van Campenhout, Peter and Deconinck, Eric and Vanhaecke, Tamara and Desmedt, Bart},
title = {Analysis of preservatives and fragrances in topical medical devices: The need for more stringent regulation},
journal = {Contact Dermatitis},
year = {2024},
doi = {10.1111/cod.14533}
}
EUVIMED